Perritt Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Perritt Capital Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,000	Closed	-$370K	–	197
2020 Q3	$370K	Sell	7,000 -2,500	-26%	-$154K	0.27%	102
2020 Q2	$582K	Sell	9,500 -500	-5%	-$28.9K	0.43%	69
2020 Q1	$566K	Hold	10,000	–	–	0.46%	64
2019 Q4	$569K	Buy	10,000 +5,100	+104%	+$270K	0.27%	106
2019 Q3	$262K	Hold	4,900	–	–	0.11%	187
2019 Q2	$293K	Buy	+4,900	New	+$308K	0.12%	193

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Perritt Capital Management's BSTC Position: Q4 2020 in Review

Perritt Capital Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 7,000 shares — an estimated $370K sold.

Perritt Capital Management first reported a position in BSTC in Q2 2019 and held it in 6 quarters. The position peaked at $582K in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Perritt Capital Management reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Perritt Capital Management sold 7,000 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $370K.
Perritt Capital Management first reported a position in BioSpecifics Technologies Corp. in Q2 2019 and held it in 6 quarters.
Perritt Capital Management's BioSpecifics Technologies Corp. position peaked at $582K in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Perritt Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.